Late Acquired Malaposition and Different Polymers

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2010
The polymers releasing the drug of first-generation drug-eluting stents (DES) may induce allergic reactions and inflammation, resulting in late-acquired stent malaposition (LASM) with uncoverage of struts, and risk of stent thrombosis. The incidence and predictors of LASM in DES with newer-generation polymers designed to improve biocompatibility are unknown.
Epistemonikos ID: a42bcf2a18af6134f82ce364989020fb7bef5970
First added on: May 11, 2024